Acura Pharmaceuticals Inc (ACUR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

616 N. NORTH COURT, SUITE 120 PALATINE, IL 60067

Acur Pharmaceuticals engages in the research, development and manufacture of innovative abuse deterrent formulations for use in orally administered opioid-containing pharmaceutical products. Plans to enter into development and commercialization agreements with strategically focused pharmaceutical company partners.

Data as of 2021-03-06 10:05:21 -0500
Market Cap6.855 Million Shares Outstanding22.105 Million Avg 30-day Volume27.987 Thousand
P/E Ratio-8.46254 Dividend Yield0.0 EPS-0.025
Price/Sales1.95 Debt to Equity-0.39 EBITDA-183.75 Thousand
Price to Book Value-1.4 Forward PE Enterprise Value13.716 Million
Total Cash493 Thousand Current Debt1.185 Million Gross Profit4.072 Million
BETA0.0 52-week High/Low0.5 / 0.12 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ACUR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 2 2 0.0% (0.0%) (0.0%)
13F shares: 1.025 Thousand 1.025 Thousand 0.0%
% Ownership 0.0047 0.0047 0.0%
New Positions:
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Acura Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding ACUR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACUR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

80 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CLEMENS PETER A SENIOR VP & CFO

  • Officer
 416,097 2021-02-24 2

EMIGH JAMES F VP, CORPORATE DEVELOPMENT

  • Officer
 474,042 2021-02-24 2

SEISER ROBERT A VP, TREASURER & CONTROLLER

  • Officer
 353,588 2021-02-24 2

ROSS GEORGE K

  • Director
 312,171 2021-01-04 1

SKELLY WILLIAM G

  • Director
 392,657 2021-01-04 1

JONES ROBERT B PRESIDENT & CEO

  • Officer
 489,889 2021-01-04 1

BRZECZKO ALBERT W VP, PHARMACEUTICAL SCIENCES

  • Officer
 368,668 2021-01-04 1

THANGARAJ IMMANUEL

  • Director
 2,220,711 2021-01-04 1

WESSON BRUCE F

  • Director
 658,716 2021-01-04 1

SCHUTTE JOHN

  • 10% Owner
 8,912,655 2019-06-28 0

ABUSE DETERRENT PHARMA, LLC

  • 10% Owner
 0 2019-06-28 0

CLAUDIUS LLC

GALEN PARTNERS INTERNATIONAL III L P

GALEN EMPLOYEE FUND III LP

GALEN MANAGEMENT, LLC

GALEN PARTNERS III L P

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 No longer subject to file 2017-12-14 0

RIVET J BRADLEY VP MARKETING

  • Officer
 0 2016-12-08 0

CARE CAPITAL II LLC

CARE CAPITAL INVESTMENTS II LP

CARE CAPITAL OFFSHORE INVESTMENTS II LP

  • 10% Owner
 No longer subject to file 2014-02-27 0

MARKHAM RICHARD J

  • Director
 0 2013-01-02 0

GCE HOLDINGS LLC

  • 10% Owner
 No longer subject to file 2012-10-01 0

ESSEX WOODLANDS HEALTH VENTURES FUND V LP

  • 10% Owner
 9,781,985 2012-10-01 0

AZAD DAVID

  • Director
 0 2012-01-03 0

REDDICK ANDREW D PRESIDENT AND CEO

  • Officer
  • Director
 1,037,346 2011-04-04 0

SUMNER WILLIAM

  • Director
 119,924 2011-01-01 0

CARE CAPITAL II LLC

CARE CAPITAL INVESTMENTS II LP

CARE CAPITAL OFFSHORE INVESTMENTS II LP

RAMSAY DAVID RUSS

  • 10% Owner
 0 2010-03-05 0

BOEHM GARTH VP MOD. REL. DOSAGE FORM DEV.

  • Officer
 0 2009-05-11 0

CARE CAPITAL II LLC

  • 10% Owner
 76,689 2009-03-24 0

SPIVEY RON J SR VP/CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2008-05-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CLEMENS PETER A - Officer SENIOR VP & CFO

2021-02-26 16:10:38 -0500 2021-02-24 M 40,000 $0.15 a 431,197 direct

SEISER ROBERT A - Officer VP, TREASURER & CONTROLLER

2021-02-26 16:11:39 -0500 2021-02-24 M 20,000 d 0 direct

EMIGH JAMES F - Officer VP, CORPORATE DEVELOPMENT

2021-02-26 16:11:10 -0500 2021-02-24 M 20,000 d 0 direct

CLEMENS PETER A - Officer SENIOR VP & CFO

2021-02-26 16:10:38 -0500 2021-02-24 M 40,000 d 0 direct

SEISER ROBERT A - Officer VP, TREASURER & CONTROLLER

2021-02-26 16:11:39 -0500 2021-02-24 F 7,550 $0.40 d 353,588 direct

EMIGH JAMES F - Officer VP, CORPORATE DEVELOPMENT

2021-02-26 16:11:10 -0500 2021-02-24 F 7,550 $0.40 d 474,042 direct

CLEMENS PETER A - Officer SENIOR VP & CFO

2021-02-26 16:10:38 -0500 2021-02-24 F 15,100 $0.40 d 416,097 direct

SEISER ROBERT A - Officer VP, TREASURER & CONTROLLER

2021-02-26 16:11:39 -0500 2021-02-24 M 20,000 $0.15 a 361,138 direct

EMIGH JAMES F - Officer VP, CORPORATE DEVELOPMENT

2021-02-26 16:11:10 -0500 2021-02-24 M 20,000 $0.15 a 481,592 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 22:15:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 21:45:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 21:15:02 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 20:45:02 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 20:15:05 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 19:45:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 19:15:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 18:45:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 18:15:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 17:45:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 17:15:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 16:45:03 UTC -92.0922 92.1622 2000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 16:15:02 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 15:45:03 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 15:15:03 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 14:45:03 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 14:15:03 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 13:45:03 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 13:15:03 UTC -92.0922 92.1622 3000
ACURA PHARMACEUTICALS INC ACUR 2021-03-05 12:45:03 UTC -92.0922 92.1622 400

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments